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Associations Between Body Mass Index and Development of
Metabolic Disorders in Fertile Women—A Nationwide Cohort Study
Michelle Dalgas Schmiegelow, MD; Charlotte Andersson, MD, PhD; Lars Køber, MD, DmSci; Søren Skøtt Andersen, MD, PhD; Mette Lykke
Norgaard, MD, PhD; Thomas Bo Jensen, MD; Gunnar Gislason, MD, PhD; Siv Mari Berger, MB; Christian Torp-Pedersen, MD, DMSci
Background-—Metabolic disorders are relatively uncommon in young women, but may increase with obesity. The associations
between body mass index (BMI) and risks of diabetes, hypertension, and dyslipidemia in apparently healthy, young women have
been insufﬁciently investigated, and are the aims of this study.
Methods and Results-—Women giving birth during the years 2004–2009, with no history of cardiovascular disease, renal
insufﬁciency, pregnancy-associated metabolic disorders, diabetes, hypertension, or dyslipidemia were identiﬁed in nationwide
registers. Women were categorized as underweight (BMI<18.5 kg/m2), normal weight (BMI=18.5 to <25 kg/m2), overweight
(BMI=25 to <30 kg/m2), obese-I (BMI=30 to <35 kg/m2), obese-II (BMI=35 to <40 kg/m2), and obese-III (BMI≥40 kg/m2). We
assessed risks by Poisson regression models (adjusted for age, calendar year; reference=normal weight). The cohort comprised
252 472 women with a median age of 30.4 years (IQR=27.2;33.7) and a median follow-up of 5.5 years (IQR=3.9;6.8). In total,
2029 women developed diabetes, 3133 women developed hypertension, and 1549 women developed dyslipidemia. Rate ratios
(RRs) of diabetes were: 0.84 (95% conﬁdence interval [CI]=0.62 to 1.14) for underweight, 2.63 (CI=2.36 to 2.93) for overweight,
4.83 (CI=4.27 to 5.47) for obese grade-I, 7.17 (CI=6.10 to 8.48) for obese grade-II, and 6.93 (CI=5.47 to 8.79) for obese grade-III
women. For hypertension, corresponding RRs were 0.86 (CI=0.69 to 1.09), 1.82 (CI=1.67 to 1.98), 2.81 (CI=2.52 to 3.13), 3.92
(CI=3.36 to 4.56), and 5.69 (CI=4.71 to 6.89), and for dyslipidemia, RRs were 1.18 (CI=0.85 to 1.65), 2.01 (CI=1.75 to 2.31), 3.11
(CI=2.61 to 3.70), 4.64 (CI=3.66 to 5.87), and 3.72 (CI=2.53 to 5.48).
Conclusions-—In this nationwide study of fertile, apparently healthy women, pre-pregnancy BMI was strongly associated with an
increased risk of diabetes, hypertension, and dyslipidemia within 5.5 years following childbirth. ( J Am Heart Assoc. 2014;3:
e000672 doi: 10.1161/JAHA.113.000672)
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A lthough now presumably stabilizing,
1 the prevalence of
obesity has been increasing at an alarming rate over the
last 4 decades,2 especially among the young.3 The cardio-
vascular consequences of obesity have a greater deleterious
impact in women ≤65 years of age.4 However, the metabol-
ically healthy but obese individuals have been shown to carry
the same risk of cardiovascular disease as metabolically
healthy and normal weight individuals, thus obesity is not
simply obesity.5 Considering the difﬁculties in identifying
these women and the potential beneﬁt of keeping them
metabolically healthy, it is important to clarify the extent to
which obesity relates to metabolic disorders in young women.
The matter is of crucial importance; especially after a recent
meta-analysis found overweight individuals to carry the lowest
age-, year-, and smoking-adjusted risk of all-cause mortality.6
Consequently, confusion may arise as to whether clinicians
should advise their overweight or obese patients, healthy or
sick, to lose weight.
The aim of this nationwide study was to assess the
associations between body mass index (BMI) and the risk of
developing the well-known cardiovascular risk factors: diabe-
tes, hypertension, and dyslipidemia in young women. Sec-
ondarily, we sought to investigate the associations between
BMI and the cumulative metabolic risk, thus the risk of
developing at least 1, 2, or 3 metabolic disorders.
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Methods
Data Sources and Deﬁnitions
From the Danish Medical Birth Register we identiﬁed women
giving birth during the years 2004-2009, with no previous
history of cardiovascular disease, renal insufﬁciency, gesta-
tional diabetes, gestational hypertension, preeclampsia, diabe-
tes, hypertension, or dyslipidemia, thus no prior cardiovascular
disease or treated metabolic disorders. Detailed information on
all women giving birth in Denmark is registered in the Medical
Birth Register together with systematic registration of height
and pre-pregnancy weight since 2004. The height and mea-
sured pre-pregnancy weight are mandatorily reported to the
Medical Birth Register at the time of birth, but obtained at the
ﬁrst antenatal appointment at the general practitioner in
gestation week 6 to 10. These antenatal routine appointments
are governmentally ﬁnanced and offered to all pregnant women
independently of socioeconomic or employee status, thus
ensuring a high rate of adherence as the general practitioners
are also responsible for the referral to the obstetrician in the
hospital setting. Furthermore, information on smoking during
pregnancy, gestational hypertension, preeclampsia, and
eclampsia was obtained from the Medical Birth Register.
We calculated BMI (weight in kilograms divided by the square
of the height in meters, kg/m2), and divided the population in 6
BMI categories according to the World Health Organization
(WHO) classiﬁcation7: underweight (BMI<18.5 kg/m2), normal
weight (BMI=18.5 to <25 kg/m2), overweight (BMI=25 to
<30 kg/m2), obese grade-I (BMI=30 to <35 kg/m2), obese
grade-II (BMI=35 to <40 kg/m2), and obese grade-III
(BMI≥40 kg/m2).7
Cross-linkage of national registers at an individual level is
possible in Denmark due to each citizen’s personal and
permanent identiﬁcation number. From the Danish Register of
Medicinal Product Statistics we obtained data on pharmaceu-
tical treatment in the 90 days prior to pregnancy (180 days for
lipid-lowering drugs8). The register has been shown to be
accurate,9 and contains all prescriptions dispensed from
Danish pharmacies according to the International Anatomical
Therapeutic Chemical (ATC) classiﬁcation system.
Diabetes prior to pregnancy was deﬁned as either
prescribed medications of glucose-lowering agents (ATC
A10) in 1 year prior to index pregnancy, or appearance in
the National Patient Register prior to the index pregnancy
(International Classiﬁcation of Diseases [ICD]-10
codes=DE10-DE14, DH360, DO24 [excluding DO244]). Inci-
dent diabetes was deﬁned as either (1) 2 prescription claims
for glucose-lowering agents within 6 months (date of second
prescription claim deﬁned as date of event), or (2) registration
in the National Patient Register with a diagnosis of diabetes.
Due to the risk of including events of gestational diabetes, we
excluded prescriptions claimed during pregnancies and
excluded prescriptions and diagnoses codes registered within
1 year following gestational diabetes (ICD 10=DO244). These
deﬁnitions have been validated.10 Hypertension was deﬁned
as either (1) prescription claims of at least 2 antihypertensive
agents within 90 days11 or, (2) a diagnosis of hypertension in
the National Patient Register (outpatient visits and hospital
admissions) with prescription of at least 1 antihypertensive
agent within 90 days. To avoid including use of antihyperten-
sive medication due to gestational hypertension or pre-
eclampsia, we excluded prescriptions collected during
pregnancies or within 1 year following a pregnancy-induced
hypertensive disorder. We considered this approach as
conservative, but acknowledge that it may potentially delay
the diagnosis of diabetes or hypertension for up to 1 year for
women who experienced a pregnancy-associated metabolic
disorder and later developed a metabolic disorder during
follow-up. Dyslipidemia was deﬁned as claimed prescriptions
of lipid-lowering medications (ATC C10A). We only had access
to data from the Medical Birth Register until 2010, but
achieved information on births in 2011 from the National
Patient Register (ICD-10=DO80-DO84); we used the dis-
charge diagnosis as date of birth and beginning of pregnancy
as 42 weeks prior to date of birth.
Pregnancy-induced metabolic disorders at baseline were
deﬁned as a discharge diagnosis from the National Patient
Register or theMedical Birth Register in previous pregnancies or
in the indexpregnancy, or prescribedglucose-lowering agents in
index pregnancy, ie, gestational hypertension (ICD 10=DO13),
preeclampsia (ICD-10=DO14), eclampsia (ICD-10=DO15), or
gestational diabetes (ICD 10=DO244). We combined all preg-
nancy-induced hypertensive disorders into one group compris-
ing preeclampsia, eclampsia, and gestational hypertension.
Outcomes
The primary outcomes were diabetes, hypertension, and
dyslipidemia (ATC C10A), and the secondary outcome was the
risk of developing at least 1, 2, or 3 metabolic disorders in
each individual.
Ethics
In Denmark, no ethics approval is needed for retrospective
register studies. This study was approved by the Danish Data
Protection Agency (2007-58-0015).
Statistical Analyses
We deﬁned the index date of inclusion as the ﬁrst date of
childbirth between January 1, 2004 and December 31, 2009.
All women were followed until outcome event, emigration,
death, or December 31, 2011, whichever came ﬁrst.
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Cumulative risk curves were based on competing risk
models, ie, Kaplan-Meier curves of the absolute incidences of
the outcomes in which the competing risk of death was taken
into account. Time-dependent multivariable Poisson regres-
sion models were used to assess the associations between
pre-pregnancy BMI and the risks of diabetes, hypertension,
and dyslipidemia, and the number of metabolic disorders in 2
steps. The main analyses were only adjusted for age and
calendar year (both variables updated yearly since index date),
ie, not adjusted for any potential intermediaries. A second
model was additionally adjusted for number of parities and
pregnancy-associated complications during follow-up (gesta-
tional hypertension, pre-eclampsia, and gestational diabetes).
Further, we assessed the impact of change in BMI over time
on our results in a subanalysis including women who gave
birth during follow-up, had no history of metabolic disorders at
date of ﬁrst birth during follow-up, and available data on BMI.
The method has been described in detail previously.12 The
model assumptions of proportionality of rate ratios over time
(by use of log(log(survival)) plots), lack of interactions and
linearity of continuous variables were tested and found valid
unless otherwise indicated. All statistical calculations were
performed using SAS for Windows, version 9.2 (SAS Institute
Inc).
Results
From the Medical Birth Register we identiﬁed 292 847
women who gave birth between the years of 2004-2009,
excluding women with prior history of cardiovascular disease
or renal insufﬁciency (n excluded=564); missing or incomplete
registration of BMI (n excluded=18 907); incorrect vital status
(n excluded=29); missing or extreme gestational age of foetus
(n excluded=246); diabetes, hypertension, or dyslipidemia at
baseline (n=5185); and gestational diabetes, gestational
hypertension, or preeclampsia (n=15 444).
The study population comprised 252 472 women with a
median age of 30.4 years (interquartile range 27.2 to 33.7).
There was a somewhat U-shaped relation between BMI-
category and active smoking during pregnancy, with the
highest frequency of active smokers among underweight and
obese women, and further, the number of parities increased
with increasing BMI (Table 1).
During a median follow-up of 5.5 years (interquartile range
3.9 to 6.8), a total number of 2029 women (0.8%, 1.5/
1000 person years) developed diabetes, 3133 women (1.2%,
2.4/1000 person years) developed hypertension, and 1549
women (0.6%, 1.2/1000 person years) developed dyslipide-
mia. Increasing pre-pregnancy BMI was strongly associated
with increasing risk of diabetes, hypertension, and dyslipide-
mia as shown in the incidence curves (Figure 1), and forest
plots illustrating the rate ratios (RRs) and absolute incidence
rates of diabetes, hypertension, and dyslipidemia adjusted for
age and calendar year (Figure 2). The results were largely
unchanged following adjustment for age; calendar year;
smoking; and as time-dependent variables: number of parities;
gestational diabetes; pregnancy-induced hypertensive disor-
der; diabetes; hypertension; and dyslipidemia (Table 2). Due
to missing data, the multivariable models only included
245 105 women. Results were similar when women with
missing data were included in the analyses using separate
categories.
A total of 6242 women (2.5%) developed at least 1
metabolic disorder during follow-up, 437 women (0.2%)
developed at least 2, and 32 women (0.01%) developed 3
metabolic disorders during the median 5.5 years of follow-up.
Compared with the risk in normal weight women and adjusted
for age and calendar year, obesity grade II and grade III were
associated with a 4-fold, 15-fold, and a 30- to 60-fold
increased RR of developing at least 1, 2, and 3 metabolic
disorders (Figure 3).
Sensitivity Analyses and Exploratory Analyses
Prescription of antihypertensive drugs during follow-up could
be due to postpartum use or due to preeclampsia during a
future pregnancy. Likewise, use of glucose-lowering agents
could be due to future gestational diabetes. We therefore
conducted sensitivity analyses, in which women were cen-
sored at the ﬁrst day of a pregnancy during follow-up, and
including only ﬁrst-time pregnancies. The overall results were
unaltered with RRs for obese grade-I women of 4.85 (CI=4.08
to 5.76) for diabetes, 2.95 (CI=2.43 to 3.58) for hypertension,
and 3.27 (CI=2.83 to 3.78) for dyslipidemia. Furthermore, for
hypertension we restricted follow-up to begin after 45 days of
follow-up (index date+45 days), which did not change our
results (RR for obese grade-I women=2.84 [CI=2.55 to 3.17]).
Biguanides, ie, metformin, are increasingly used to treat
polycystic ovary syndrome, and we therefore conducted a
sensitivity analysis excluding use of oral glucose-lowering
agents to identify individuals with diabetes. Despite a
substantial decrease in the number of incident cases of
diabetes (n=974 versus n=2029), the RRs did not change
substantially: 1.01 (CI=0.69 to 1.48) for underweight, 2.22
(CI=1.91 to 2.59) for overweight, 3.23 (CI=2.67 to 3.92) for
obese grade-I, 5.88 (CI=4.64 to 7.45) for obese grade-II, and
6.42 (CI=4.60 to 8.95) for obese grade-III women.
A subanalysis evaluating associations between weight
change and metabolic risk included 86 758 women who gave
birth during follow-up (n=108 034 women), with no history of
metabolic disorders at date of ﬁrst birth during follow-up
(n excluded=3133), and available data on pre-pregnancy BMI
for the birth during follow-up (n excluded=18 143). Although
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weight gain was associated with increased risk of metabolic
disorders in unadjusted analyses, these associations were
attenuated following adjustment for baseline BMI category,
whereas the associations between BMI category and the
metabolic disorders were similar to our main results (Table 3).
Our overall results were unaltered following adjustment for
educational attainment with RRs for obese grade-I women of
4.86 (95% CI=4.27 to 5.53) for diabetes, 2.52 (95% CI=2.34
to 2.92) for hypertension, and 2.73 (95% CI=2.29 to 3.26) for
dyslipidemia (Table 4). There was no interaction between age
and highest attained educational level for hypertension (P for
interaction=0.92) or for dyslipidemia (P for interaction=0.17),
but only for diabetes (P for interaction< 0.001). We found no
associations between educational attainment and diabetes for
women <35 years of age. However, being ≥35 years old with
only basic school education was associated with a higher risk
of diabetes than in other age groups: RRs of diabetes were
0.63 (95% CI 0.43 to 0.92) for upper secondary, 0.74 (95% CI
0.58 to 0.95) for vocational, 0.57 (95% CI 0.44 to 0.74) for
short or medium length, and 0.55 (95% CI 0.38 to 0.79) for a
master’s degree or PhD as highest attained education. The
associations between BMI categories and risk of diabetes were
nonetheless unaffected.
Discussion
In this nationwide study of 252 472 fertile women with a
median age of 30.4 years without prior cardiovascular
disease, renal insufﬁciency, diabetes, hypertension, dyslipide-
mia or any pregnancy-associated metabolic disorders, we
found pre-pregnancy BMI to be strongly associated with
Table 1. Baseline Characteristics According to BMI-Categories for 252 472 Women, Who Have Given Birth
Variables
BMI-Category (kg/m2)
<18.5
(n=11 201)
18.5 to <25.0
(n=165 933)
25.0 to <30.0
(n=50 358)
30.0 to <35.0
(n=17 012)
35.0 to <40.0
(n=5598)
≥40.0
(n=2370)
Median age,
IQR
29.0 (25.2;32.5) 30.5 (27.4;33.8) 30.4 (27.1;33.9) 30.1 (26.7;33.6) 29.9 (26.4;33.4) 30.0 (26.6;33.4)
Median
follow-up
in years,
IQR
5.4 (3.8;6.8) 5.5 (3.8;6.8) 5.6 (3.9;6.8) 5.6 (3.9;6.8) 5.5 (3.9;6.8) 5.5 (3.9;6.8)
Median pre-
pregnancy
BMI, IQR
17.9 (17.4;18.3) 21.8 (20.4;23.2) 26.8 (25.8;28.1) 31.8 (30.8;31.1) 36.8 (35.8;38.1) 42.5 (41.0;45.0)
Smoking during pregnancy*
Never or
ceased in
pregnancy
8500 (77.3%) 142 371 (87.5%) 42 021 (85.2%) 13 794 (82.9%) 4449 (81.2%) 1898 (82.2%)
Active in
pregnancy
2494 (22.7%) 20 354 (12.5%) 7289 (14.8%) 2925 (17.1%) 1031 (18.8%) 411 (17.8%)
Ethnicity†
Danish 9032 (82.6%) 143 477 (86.5%) 43 482 (86.4%) 14 954 (87.9%) 5074 (90.7%) 2214 (93.4%)
Immigrants 1930 (17.2%) 12 398 (12.3%) 6298 (12.5%) 1895 (11.1%) 466 (8.3%) 136 (5.7%)
Offspring
of first
generation
immigrants
238 (2.1%) 2034 (1.2%) 574 (1.1%) 165 (1.0%) 57 (1.0%) 20 (0.8%)
Parity including index pregnancy‡
1 6744 (60.9%) 94 945 (57.8%) 25 915 (52.0%) 8384 (49.8%) 2676 (48.3%) 1137 (48.6%)
2 2907 (26.2%) 44 903 (27.3%) 14 378 (28.8%) 4992 (29.7%) 1719 (31.0%) 707 (30.2%)
3 11 081 (9.8%) 19 275 (11.7%) 6889 (13.8%) 2345 (13.9%) 768 (13.9%) 338 (14.4%)
≥4 345 (3.1%) 5282 (3.2%) 2684 (5.4%) 1116 (6.6%) 377 (6.8%) 159 (6.8%)
P value was <0.001 for all baseline characteristics unless otherwise indicated. BMI indicates body mass index; IQR, interquartile range.
*Data missing for 5014 women (2.0%).
†Data missing for 32 women (0.01%).
‡Data missing for 2406 women (0.9%).
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increased risk of developing diabetes, hypertension, and
dyslipidemia requiring intervention within 5.5 years after
childbirth. Additionally, a BMI≥35 kg/m2 was associated with
a 4-fold, 15-fold, and a 30- to 60-fold increased rate ratio of
developing at least 1, 2, or 3 metabolic disorders compared
with normal weight women. Due to the rarity of developing
multiple disorders requiring intervention in this young, healthy
population, the conﬁdence intervals became increasingly wide
but were highly signiﬁcant, and the rate ratios were disturb-
ingly high. Thus, the key message of this study is that despite
young age, obesity is closely related to development of
metabolic disorders requiring intervention in healthy, fertile
women, even in the short term.
Our ﬁndings add knowledge to the debate of how to handle
obesity. Evidence is increasing about the appropriateness of
distinguishing between metabolically unhealthy obese, and
metabolically healthy obese, the latter of which is found to
have a cardiovascular risk that resembles the metabolically
healthy normal weight individuals.5 These metabolic disorders
are recognized cardiovascular risk factors, and with the early
onset in our study of young women, these women can be
assumed to be at higher risk of early-onset cardiovascular
disease. Young women especially are found to have a poorer
prognosis following stroke and myocardial infarction,13,14 thus
emphasizing the need to keep these women metabolically
healthy. The high rate ratios of developing a metabolic
disorder associated with overweight and obesity in our study
of apparently healthy, young women, suggest the importance
of keeping BMI within the normal range via physical activity
and a healthy diet. Women, especially those who are obese,
might also be strongly encouraged to optimize all cardiovas-
cular risk factors, such as smoking cessation, in addition to
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Figure 1. Cumulative incidence of diabetes (A), hypertension (B), and dyslipidemia (C) according to BMI categories. BMI indicates body mass
index.
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striving to achieve normal weight. Using a different population
and only discharge diagnoses for the deﬁnitions of diabetes
and hypertension, a recent study examined the impact of
obesity on the risks of type 2 diabetes, cardiovascular
morbidity and death in young men <55 years of age over
33 years of follow-up.15 The relative risks are comparable to
ours, although the study might have underestimated the
incidence of hypertension by only using the National Patient
Register, which does not contain data from the general
practitioner, ie, uncomplicated hypertension was not identi-
ﬁed. The risk of type 2 diabetes strongly resembled the
estimates in our female population. For hypertension,
the relative risk in overweight men was also similar, whereas
the relative association with obesity was approximately half.
These results indicate that the relative risk of developing
diabetes is increased for both obese men and obese women,
whereas obese women might carry an excess risk of
hypertension compared with men. Additionally, a previous
case-control study demonstrated a higher sex-speciﬁc impact
of hypertension and diabetes on future risk of coronary heart
disease in women.4 If obesity is associated with a greater
relative risk of hypertension in women, and hypertension is
associated with a greater risk of coronary heart disease in
women, sex-speciﬁc strategies for prevention of hypertension
and diabetes might be beneﬁcial. An American study of
secular trends in cardiovascular risk factors according to BMI
categories found that the prevalence of hypertension and
dyslipidemia had decreased partly due to increased use of
antihypertensive and lipid-lowering drugs, whereas the prev-
alence of diabetes had remained stable.16 However, as a
consequence of the obesity epidemic, many individuals have
shifted to heavier weight categories, thus increasing the
overall burden on the health care system, including expenses
of risk factor-modifying medications, especially as our data
support that overweight and obesity is associated with early-
age onset of the risk factors.
Although we had a shorter follow-up period and a selected
population of women who gave birth twice or more during
follow-up, we found a tendency towards increased risks of
developing hypertension, diabetes, or dyslipidemia among
those who experienced weight gain between pregnancies. The
tendency towards increased risks associated with weight loss
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Figure 2. Rate ratios of diabetes (A), hypertension (B), and dyslipidemia (C) according to BMI-categories and adjusted for age and calendar
year using the normal weight women as a reference. BMI indicates body mass index; CI, 95% conﬁdence interval; IR, incidence rate; RR, rate
ratio.
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in unadjusted analyses seems contradictory. These ﬁndings
may be a result of a higher age among the women
experiencing weight loss or that the weight loss was
motivated by, eg, borderline hypertension, thus that women
experiencing weight loss had a higher a priori risk of
developing metabolic disorders. Importantly, however, the
associations between pre-pregnancy BMI and risk of the
disorders were largely unchanged.
Strengths and Limitations
While the epidemiological approach has limitations, this study
provides several strengths: it is a nationwide study, which
minimizes the risk of demographic selection bias; the compre-
hensive Danish registers ensure a minimal loss to follow-up;
and the large study population makes it possible to study
relatively rare events and risk factors. We wished to study a
young population in which metabolic disorders are uncommon,
but where a high BMI may or may not display deleterious
effects on metabolism despite a low baseline rate. The Medical
Birth Register was ideal for our study aim, as glucose
abnormalities and blood pressure are closely monitored
throughout pregnancy.
The primary limitation of this study is the use of
prescription claims and diagnoses from the hospitals and
outpatient clinics to deﬁne diabetes, hypertension, and
dyslipidemia, which could potentially underestimate the true
incidence rates of especially dyslipidemia. Further, we cannot
rule out a selection bias, whereby the clinician may be more
likely to screen for metabolic disorders or perhaps even
Table 2. Multivariable Poisson Regression Analyses of the Associations Between BMI-Categories and Risks of Diabetes,
Hypertension and Dyslipidemia in 245 105* Fertile Women
Diabetes Hypertension Dyslipidemia
RR 95% CI RR 95% CI RR 95% CI
BMI-category
Underweight 0.74 0.51 to 1.08 0.83 0.66 to 1.06 1.09 0.78 to 1.53
Normal weight (ref) NA (ref) NA (ref) NA
Overweight 2.70 2.38 to 3.07 1.72 1.57 to 1.87 1.83 1.59 to 2.11
Obese grade-I 4.85 4.19 to 5.61 2.61 2.34 to 2.92 2.45 2.05 to 2.94
Obese grade-II 7.56 6.26 to 9.12 3.54 3.03 to 4.13 3.41 2.67 to 4.35
Obese grade-III 7.36 5.62 to 9.64 4.98 4.10 to 6.05 2.11 1.40 to 3.18
Age (continuous variable) 0.99 0.98 to 1.00 1.10 1.09 to 1.11 1.09 1.08 to 1.11
Active smoking 0.94 0.82 to 1.09 1.22 1.11 to 1.34 2.46 2.16 to 2.80
Calendar year
2004–2005 (ref) NA (ref) NA (ref) NA
2006–2007 1.42 1.16 to 1.73 1.05 0.90 to 1.21 1.76 1.32 to 2.35
2008–2009 1.77 1.47 to 2.12 1.12 0.98 to 1.30 2.09 1.60 to 2.74
2010–2011 1.97 1.65 to 2.35 1.26 1.09 to 1.45 2.42 1.86 to 3.13
Total number of parities
1 (ref) NA (ref) NA (ref) NA
2 0.40 0.35 to 0.45 1.31 1.19 to 1.45 1.07 0.92 to 1.26
3 0.37 0.31 to 0.44 1.45 1.30 to 1.63 1.16 0.96 to 1.39
4 0.49 0.39 to 0.62 1.67 1.45 to 1.92 1.51 1.22 to 1.87
Gestational diabetes 28.09 17.72 to 44.55 1.04 0.26 to 4.15 2.24 0.31 to 15.90
Pregnancy-induced hypertensive disorder† 2.16 1.16 to 4.05 6.19 4.88 to 7.87 1.11 0.46 to 2.67
Diabetes NA NA 1.92 1.45 to 2.54 10.02 7.92 to 12.71
Hypertension 1.78 1.24 to 2.58 NA NA 6.93 5.59 to 8.59
Dyslipidemia 9.76 7.37 to 12.92 7.90 6.47 to 9.65 NA NA
For absolute incidence rates please see Figure 2. 95% CI indicates 95% conﬁdence interval; BMI, body mass index; NA, not applicable; RR, rate ratio.
*Due to missing data.
†Gestational hypertension. preeclampsia or eclampsia.
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initiate treatment in obese women. A woman with a history of
a metabolic disorder may also be more likely to be monitored
for other cardiovascular risk factors, but it is also reasonable
of the clinician to assume that if obesity increases the
woman’s risk in one aspect, other obesity-related metabolic
disorders are likely to follow.
Although we cannot preclude that some of the events of
hypertension were due to postpartum treatment for pre-
eclampsia, sensitivity analyses did not change our results. For
diabetes events, some of these might be women receiving
biguanides because of polycystic ovary syndrome, a syndrome
that can be regarded as a metabolic disorder with a
prevalence of 5% to 10% in Danish fertile women. It increases
the risk of diabetes and cardiovascular disease, and because
it is mostly diagnosed in the non-hospital setting, it might not
be possible to identify in the national registers. However, a
sensitivity analysis excluding prescriptions of oral glucose-
lowering agents did not change the overall results.
Only BMI was available from the Medical Birth Register,
and although it would have been preferable to have other
anthropometric measures of obesity and body fat distribution,
the WHO has recommended BMI as a useful population-level
measure of obesity.17 BMI makes results between studies
more comparable, and a review concluded that other anthro-
pometric measures were not superior to BMI regarding a wide
range of cardiovascular disease risk factors.18 Nevertheless, it
is increasingly acknowledged that BMI must be regarded only
as the ﬁrst step in the overall risk assessment. Future risk
assessment should preferably include evaluation of the
woman’s physical activity level or alcohol consumption,
information that is not available from the Danish registers.
Physical activity is known to improve especially glucose
metabolism,19 although obesity is a stronger determinant of
diabetes than physical activity.20 Socioeconomic status is
known to be associated with obesity and lifestyle habits,21 but
subanalyses including highest attained educational level left
our overall ﬁndings unchanged. However, caution is warranted
when interpreting the estimates, as many of the women are
still undergoing education at the time of delivery. Although a
teenage pregnancy potentially indicates lower socioeconomic
status, highest attained level of education may not accurately
reﬂect current socioeconomic status.
Running a prospective study with sufﬁcient power to
examine metabolic disorders in a female population as young
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Figure 3. Rate ratios of developing at least 1 metabolic disorder (A), at least 2 metabolic disorders (B), or 3 metabolic disorders (C) according
to BMI-categories and adjusted for age and calendar year using the normal weight women as a reference. BMI indicates body mass index; CI,
95% conﬁdence interval; IR, incidence rate; RR, rate ratio.
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as in our study is very unlikely, which makes these data
unique and leaves the key message of our study unchanged:
The health-related consequences of obesity become apparent
at an early age, which increases the burden on the health care
system, increases the economic costs for the individual and
increases the risks of cardiovascular disease.
In conclusion, in this nationwide study of fertile, apparently
metabolically healthy women, increasing pre-pregnancy BMI
was strongly associated with increased risk of hypertension,
dyslipidemia, and diabetes within only 5.5 years of childbirth.
In addition, individuals with a BMI≥35 kg/m2 had a 15-fold
increased risk of developing at least 2 metabolic disorders
and a 30- to 60-fold increased risk of developing 3 metabolic
disorders requiring intervention. BMI may thus be used to
identify women for whom lifestyle intervention is important,
and by referring to the short-term consequences, our results
might promote guidance and motivation for lifestyle changes
in young, healthy, obese women.
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Unadjusted
Diabetes Hypertension Dyslipidemia
RR (95% CI) IR/1000 PYs RR (95% CI) IR/1000 PYs RR (95% CI) IR/1000 PYs
Change in BMI
Weight loss, >1 kg/m2
(n=13 454; 15.5%)
1.40 (0.98 to 2.02) 1.0 1.28 (0.99 to 1.64) 0.8 1.40 (0.98 to 2.02) 1.0
Stable BMI, 1 kg/m2
(n=44 277; 51.0%)
(ref) 0.7 (ref) 0.6 (ref) 0.7
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>1 to 2 kg/m2
(n=13 414; 15.5%)
1.76 (1.26 to 2.48) 1.2 1.32 (1.02 to 1.70) 0.8 1.21 (0.82 to 1.78) 0.8
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>2 kg/m2 (n=15 643; 18.0%)
2.10 (1.54 to 2.85) 1.4 1.84 (1.48 to 2.29) 1.1 1.92 (1.40 to 2.63) 1.3
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Change in BMI
Weight loss, >1 kg/m2 0.85 (0.57 to 1.27) 1.12 (0.80 to 1.44) 1.06 (0.71 to 1.60)
Stable BMI, 1 kg/m2 (ref) (ref) (ref)
Minor weight gain,
>1 to 2 kg/m2
1.43 (0.98 to 2.09) 1.24 (0.93 to 1.66) 1.03 (0.68 to 1.58)
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>2 kg/m2
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95% CI indicates 95% conﬁdence interval; BMI, body mass index; IR, incidence rate; PYs, person years; RR, rate ratio.
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